ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Australian State/Territory : VIC
Field of Research : Medical Biotechnology
Research Topic : abnormal neurodevelopment
Clear All
Filter by Field of Research
Medical Biotechnology (3)
Medical Molecular Engineering of Nucleic Acids and Proteins (2)
Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies) (1)
Biochemistry and Cell Biology (1)
Medical Biotechnology Diagnostics (incl. Biosensors) (1)
Oncology And Carcinogenesis (1)
Protein Targeting And Signal Transduction (1)
Virology (1)
Filter by Socio-Economic Objective
Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classified (2)
Cancer and related disorders (1)
Digestive system and disorders (1)
Expanding Knowledge in Technology (1)
Expanding Knowledge in the Medical and Health Sciences (1)
Human Pharmaceutical Products not elsewhere classified (1)
Organs, diseases and abnormal conditions not elsewhere classified (1)
Filter by Funding Provider
Australian Research Council (3)
Filter by Status
Closed (3)
Filter by Scheme
Linkage Projects (2)
ARC Future Fellowships (1)
Filter by Country
Australia (3)
Filter by Australian State/Territory
VIC (3)
QLD (1)
  • Researchers (4)
  • Funded Activities (3)
  • Organisations (6)
  • Funded Activity

    ARC Future Fellowships - Grant ID: FT0991472

    Funder
    Australian Research Council
    Funding Amount
    $788,800.00
    Summary
    Molecular signals that regulate the regenerative properties of intestinal epithelial cells. Most cancer deaths are due to the cancer spreading to other organs. Cancer is much more difficult to treat once it has spread to other organs in the body where the cancer cells can exist in a dormant state. Dormant cancer cells evade conventional anticancer treatment and can remain dormant for a very long time before they change back to a 'tumour-growing' state. An understanding of how the cancer initiati .... Molecular signals that regulate the regenerative properties of intestinal epithelial cells. Most cancer deaths are due to the cancer spreading to other organs. Cancer is much more difficult to treat once it has spread to other organs in the body where the cancer cells can exist in a dormant state. Dormant cancer cells evade conventional anticancer treatment and can remain dormant for a very long time before they change back to a 'tumour-growing' state. An understanding of how the cancer initiating (stem cell) property of tumour cells is maintained offers potential novel avenues to eliminate persistent cancer cells. This knowledge will ultimately lead to better management and treatment of cancer, and increase survival. An understanding of stem cell behaviour is also central to the control of degenerative conditions.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP120100626

    Funder
    Australian Research Council
    Funding Amount
    $490,000.00
    Summary
    The first integrated multimodal assay for the ultrasensitive detection of dengue contamination of blood. This project will develop the first screening test to check for dengue contamination of blood donations in Australia. This will help ensure safe, continued supply from blood donors, particularly in Queensland where dengue is on the rise.
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP130100531

    Funder
    Australian Research Council
    Funding Amount
    $495,000.00
    Summary
    Intracellular trafficking and function of a recycling receptor which prolongs the serum half-life of novel therapeutic proteins. The life span of recombinant engineered proteins for therapeutic use is a critical factor in their effectiveness, ease of clinical application and cost. This project will exploit interactions with a natural receptor, which prolongs the lifespan of serum proteins, to enhance survival of therapeutic engineered proteins.
    More information

    Showing 1-3 of 3 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback